Financials data is unavailable for this security.
View more
Year on year China Health Group Inc had net income fall 267.82% from a loss of 15.83m to a larger loss of 58.21m despite a 63.67% increase in revenues from 13.09m to 21.43m. An increase in the selling, general and administrative costs as a percentage of sales from 166.54% to 310.59% was a component in the falling net income despite rising revenues.
| Gross margin | 42.55% |
|---|---|
| Net profit margin | -229.55% |
| Operating margin | -228.29% |
| Return on assets | -35.50% |
|---|---|
| Return on equity | -47.26% |
| Return on investment | -47.26% |
More ▼
Cash flow in CNYView more
In 2023, China Health Group Inc did not generate a significant amount of cash. However, the company earned 1.12m from its operations for a Cash Flow Margin of 5.23%. In addition the company used 1.04m on investing activities and also paid in financing cash flows.
| Cash flow per share | -- |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 0.1019 |
|---|---|
| Tangible book value per share | 0.1019 |
More ▼
Balance sheet in CNYView more
| Current ratio | 3.23 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in CNY
Year on year, growth in earnings per share excluding extraordinary items dropped -267.80%.
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -- |
